The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Chlorotoxin, a scorpion‐derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin
Abstract
Highly migratory neuroectodermal cells share a common embryonic origin with cells of the central nervous system (CNS). They include enteric, parasympathetic, sympathoadrenal, and sensory neurons of the peripheral nervous system, Schwann cells, melanocytes, endocrine cells, and cells forming connective tissue of the face and neck. Because of their common embryologic origin, these cells and the tumors that derive from them can share genetic and antigenic phenotypes with gliomas, tumors derived from CNS glia. We recently discovered that chlorotoxin (ClTx), a 4‐kD peptide purified from Leiurus quinquestriatus scorpion, is a highly specific marker for glioma cells in biopsy tissues (Soroceanu et al. Cancer Res 58:4871–4879, 1998) that can target tumors in animal models. We report on the specificity of ClTx as a marker for tumors of neuroectodermal origin that include peripheral neuroectodermal tumors (PNET) and gliomas. Specifically, we histochemically stained frozen and paraffin tissue sections of human biopsy tissues from 262 patients with a synthetically manufactured and biologically active ClTx bearing an N‐terminal biotin. The vast majority (74 of 79) of primary human brain tumors investigated showed abundant binding of ClTx with greater than 90% ClTx‐positive cells in each section. By comparison, 32 biopsies of uninvolved brain used for comparison were largely ClTx‐negative, with only a few isolated reactive astrocytes showing some ClTx binding. However, as with gliomas, the vast majority of PNETs examined showed specific ClTx binding (31 of 34). These include medulloblastomas (4 of 4), neuroblastomas (6 of 7), ganglioneuromas (4 of 4), melanomas (7 of 7), adrenal pheochromocytomas (5 of 6), primitive PNET (1), small cell lung carcinoma (2 of 3), and Ewing's sarcoma (2 of 2). Under identical staining conditions, normal tissues from brain, skin, kidney, and lung were consistently negative for ClTx. These results suggest that chlorotoxin is a reliable and specific histopathological marker for tumors of neuroectodermal origin and that chlorotoxin derivatives with cytolytic activity may have therapeutic potential for these cancers. GLIA 39:162–173, 2002. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The New WHO Classification of Brain Tumours
Kleihues, P., Burger, P. C., & Scheithauer, B. W. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00752.x · Cited by 1,587
Molecular profile of reactive astrocytes—Implications for their role in neurologic disease
Eddleston, M., & Mucke, L. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90380-x · Cited by 1,431
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
Frederick, L. A., Wang, X. Y., Eley, G. D., & James, C. D. (2000) · PubMed · Cited by 661
DeBin, J. A., Maggio, J. E., & Strichartz, G. R. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.2.c361 · Cited by 407
Modulation of Glioma Cell Migration and Invasion Using Cl−and K+Ion Channel Blockers
Soroceanu, L., Manning, T. J., & Sontheimer, H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05942.1999 · Cited by 306
Self-citationBatra, S. K., Castelino‐Prabhu, S., Wikstrand, C. J., Zhu, X., Humphrey, P. A., Friedman, H. S., & Bigner, D. D. (1995) · PubMed · Cited by 281
Ekstrand, A. J., Longo, N., Hamid, M. L., Olson, J. J., Liu, L., Collins, V. P., & James, C. D. (1994) · PubMed · Cited by 255
Huang, S.-M., & Harari, P. M. (1999) · Investigational New Drugs · doi:10.1023/a:1006384521198 · Cited by 253
Growth Factors in Glioma Angiogenesis: FGFs, PDGF, EGF, and TGFs
Dunn, I. F., Heese, O., & Black, P. M. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006436624862 · Cited by 246
Use of chlorotoxin for targeting of primary brain tumors.
Soroceanu, L., Gillespie, G. Y., Khazaeli, M. B., & Sontheimer, H. W. (1998) · PubMed · Cited by 237
Self-citationThe Extracellular Matrix of Gliomas: Modulation of Cell Function
Gladson, C. L. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199910000-00001 · Cited by 199
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Anticancer Agents
Ciardiello, F. (2000) · Drugs · doi:10.2165/00003495-200060001-00003 · Cited by 194
Bigner, D. D., Brown, M. T., Friedman, A. H., Coleman, R. E., Akabani, G., Friedman, H. S., Thorstad, W. L., McLendon, R. E., Bigner, S. H., Zhao, X. G., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2202 · Cited by 192
Gene amplification in human gliomas
Collins, V. P. (1995) · Glia · doi:10.1002/glia.440150309 · Cited by 149
Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.
Chi, D. D., Merchant, R. E., Rand, R., Conrad, A. J., Garrison, D., Turner, R. R., Morton, D. L., & Hoon, D. S. �. (1997) · Europe PMC (PubMed Central) · Cited by 146
The autocrine loop of TGF-α/EGFR and brain tumors
Tang, P., Steck, P. A., & Yung, W. K. A. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005824802617 · Cited by 132
Phenotype vs Genotype in the Evolution of Astrocytic Brain Tumors
Kleihues, P., & Ohgaki, H. (2000) · Toxicologic Pathology · doi:10.1177/019262330002800121 · Cited by 119
Tumor antigens in astrocytic gliomas
Kurpad, S. N., Zhao., X. ‐., Wikstrand, C. J., Batra, S. K., McLendon, R. E., & Bigner, D. D. (1995) · Glia · doi:10.1002/glia.440150306 · Cited by 113
Ricotti, E., Fagioli, F., Garelli, E., Linari, C., Crescenzio, N., Horenstein, A. L., Pistamiglio, P., Vai, S., Berger, M., diMontezemolo, L. C., et al. (1998) · Blood · doi:10.1182/blood.v91.7.2397 · Cited by 108
Expression of voltage-activated chloride currents in acute slices of human gliomas
Ullrich, N. J., Bordey, A., Gillespie, G. Y., & Sontheimer, H. W. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00456-9 · Cited by 107
Self-citationUllrich, N. J., & Sontheimer, H. W. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.4.c1290 · Cited by 106
Self-citationKawauchi, S., Fukuda, T., Miyamoto, S., Yoshioka, J.-I., Shirahama, S., Saito, T., & Tsukamoto, N. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199811000-00013 · Cited by 99
Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells
Ullrich, N. J., & Sontheimer, H. W. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.5.c1511 · Cited by 86
Self-citationRas Activation in Astrocytomas and Neurofibromas
Guha, A. (1998) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100034272 · Cited by 71
Human astrocytoma cells express a unique chloride current
Ullrich, N. J., Gillespie, G. Y., & Sontheimer, H. W. (1996) · Neuroreport · doi:10.1097/00001756-199604100-00013 · Cited by 58
Self-citationWiltshire, R. N., Rasheed, B. K. A., Friedman, H. S., et al. (2000) · Neuro-Oncology · doi:10.1093/neuonc/2.3.164 · Cited by 53
EGFRvIII as a promising target for antibody-based brain tumor therapy
Kuan, C., Wikstrand, C. J., & Bigner, D. D. (2000) · Brain Tumor Pathology · doi:10.1007/bf02482738 · Cited by 49
Krasagakis, K., Garbe, C., & Orfanos, C. E. (1993) · PubMed · Cited by 30
Krasagakis, K., Garbe, C., & Orfanos, C. E. (1993) · Melanoma Research · doi:10.1097/00008390-199311000-00005 · Cited by 29
Expression of a Truncated Epidermal Growth Factor Receptor-like Protein (TEGFR) in Ovarian Cancer
Ilekis, J. V., Gariti, J., Niederberger, C., et al. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1996.4526 · Cited by 24
Cited by
Magnetic nanoparticles in MR imaging and drug delivery
Sun, C., Lee, J. S. H., & Zhang, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.018 · Cited by 2,594
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 883
Therapeutic potential of venom peptides
Lewis, R. J., & Garcia, M. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1197 · Cited by 798
Optical and MRI Multifunctional Nanoprobe for Targeting Gliomas
Veiseh, O., Sun, C., Gunn, J., Kohler, N., Gabikian, P., Lee, D., Bhattarai, N., Ellenbogen, R., Sze, R., Hallahan, A., et al. (2005) · Nano Letters · doi:10.1021/nl0502569 · Cited by 564
Navigating CAR-T cells through the solid-tumour microenvironment
Hou, A. J., Chen, L. C., & Chen, Y. Y. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00189-2 · Cited by 551
Metadata
- Authors
- Lyons, S. A., O'Neal, J., & Sontheimer, H.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2002-05-29
- Volume
- 39
- Issue
- 2
- Pages
- 162-173
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2072058809
- Cited by
- 263
- References
- 30
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.